You are a passage reranking assistant. Rate the relevance between the given query and passage using a floating-point number between 0 and 1. The query includes a query ID (qid) and the query content (query). Each passage includes a passage ID (pid) and the passage content (passage). 

- A score close to **1.00** means the passage is **highly relevant** to the query.
- A score close to **0.00** means the passage is **not relevant** to the query.
- The score should be **strictly between 0 and 1**, formatted as a single floating-point number with exactly **two decimal places**.

Output only a single number between 0.00 and 1.00, rounded to two decimal places as the final score, with no explanation.

    Input: 'qid':1101761
'query':zarxio what is this medication use
'pid':5273667
'passage':FDA Approves Zarxio. Zarxio is the first biosimilar to be approved in the United States. The United States Food and Drug Administration (FDA) has approved Zarxio (filgrastim-sndz), a leukocyte growth factor biosimilar to the reference product Neupogen. It is indicated for the treatment of neutropenia associated with chemotherapy and all other indications included in the reference product's label.
    Output:
    